Literature DB >> 9064463

[Colorectal carcinoma. Which factors are decisive for development of postoperative complications?].

C Tonus1, O Keller, R Kropp, H Nier.   

Abstract

This retrospective study analyses the prognostic effect of different factors on morbidity and lethality based on selected, primarily resecting colon carcinoma operations (n = 222). In all, 12.2% of our operations were performed under emergency conditions. The total complication rate was 31.5%, the lethality rate 7.7%. The left hemicolectomy cases showed the highest morbidity (48.4%), the rectum amputation the highest lethality (11.8%). Tumour staging tumour differentiation and the sex of the patient showed no significant influence on the postoperative morbidity and lethality. However, a correlation was proved between the age of the patient, tumour localisation, co-morbidity, duration of operation and the conditions under which the operation was performed (emergency or elective), on the one hand, and morbidity and lethality on the other.

Entities:  

Mesh:

Year:  1996        PMID: 9064463     DOI: 10.1007/bf00184045

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  17 in total

Review 1.  [Lymphadenectomy as the primary therapy of colorectal cancers].

Authors:  C Herfarth; P Hohenberger
Journal:  Chirurg       Date:  1989-03       Impact factor: 0.955

2.  [Change and current status of surgical treatment of colorectal cancer. Report of experiences of the Erlangen Surgical University Clinic].

Authors:  F P Gall; P Hermanek
Journal:  Chirurg       Date:  1992-04       Impact factor: 0.955

3.  [Surgery of colon and rectal cancer].

Authors:  G Jatzko; M Müller
Journal:  Wien Med Wochenschr       Date:  1988-07-15

Review 4.  [Surgical preparation and technic and perioperative therapy in colorectal interventions: state of the art review].

Authors:  R Grundmann; F Weber; H Pichlmaier
Journal:  Med Klin (Munich)       Date:  1987-07-17

5.  [Perioperative use of ampicillin/sulbactam, cefoxitin and piperacillin/ metronidazole in elective colon and rectal surgery. A prospective randomized quality assurance study of 422 patients].

Authors:  J Menzel; J Bauer; E von Pritzbuer; I Klempa
Journal:  Chirurg       Date:  1993-08       Impact factor: 0.955

6.  Surgery for large bowel cancer in people aged 75 years and older.

Authors:  J E Payne; P H Chapuis; M T Pheils
Journal:  Dis Colon Rectum       Date:  1986-11       Impact factor: 4.585

7.  [Prognosis of colorectal cancer in patients over 80].

Authors:  L Braun
Journal:  Dtsch Med Wochenschr       Date:  1986-12-05       Impact factor: 0.628

8.  Surgical results in 657 patients with colorectal cancer.

Authors:  M J Turunen; P Peltokallio
Journal:  Dis Colon Rectum       Date:  1983-09       Impact factor: 4.585

9.  Operative mortality following surgery for colorectal cancer.

Authors:  J L Canivet; P Damas; C Desaive; M Lamy
Journal:  Br J Surg       Date:  1989-07       Impact factor: 6.939

10.  [Wound healing disorder in surgery of colorectal cancer--a multifactorial computer analysis].

Authors:  J Fass
Journal:  Langenbecks Arch Chir       Date:  1985
View more
  3 in total

1.  Anastomotic leakage following low anterior resection: results of a standardized diagnostic and therapeutic approach.

Authors:  C Eckmann; P Kujath; T H K Schiedeck; H Shekarriz; H-P Bruch
Journal:  Int J Colorectal Dis       Date:  2003-05-13       Impact factor: 2.571

2.  Risk factors for clinical anastomotic leakage and postoperative mortality in elective surgery for rectal cancer.

Authors:  Martin Kruschewski; Hayo Rieger; Uwe Pohlen; Hubert G Hotz; Heinz J Buhr
Journal:  Int J Colorectal Dis       Date:  2007-01-27       Impact factor: 2.796

3.  Long-term efficacy of vacuum-assisted therapy (Endo-SPONGE®) in large anastomotic leakages following anterior rectal resection.

Authors:  Alessandro Mussetto; Rosario Arena; Andrea Buzzi; Lorenzo Fuccio; Silvia Dari; Mario Luciano Brancaccio; Omero Triossi
Journal:  Ann Gastroenterol       Date:  2017-09-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.